Clinical Trial for evaluation of the clinical effect of on line hemodiafiltration (HDF) and beta2-microglobulin adsorption column combination therapy

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2012
INTERVENTION: Change from hemodialysis (HD) to on line HDF (1st phase: for 4 months) Combine on line HDF and beta2‐microglobulin adsorption column. (2nd phase: for 4 months) Return from on line HDF and beta2‐microglobulin adsorption column combination to on line HDF only (3rd phase, same as 1st phase: for 4 months) CONDITION: dialysis‐related amyloidosis PRIMARY OUTCOME: Improvement of clinical symptoms, circulatory dynamics, and nutritional and inflammatory status. INCLUSION CRITERIA: (1)Patients who has initiated hemodialysis before more than 10 years. (2)Patients with dialysis‐related amyloidosis or similar symptoms.
Epistemonikos ID: a0f5fd9cbab5ba348713f270cf469c45425500e8
First added on: Aug 22, 2024